Announcement PDF Appendix 3Y Change of Director’s Interest Notice Appendix 3Y Rule 3.19A.2 Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Starpharma Holdings Limited ABN 20 078 532 180 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Dr Jacinth K Fairley Date of last notice 9 September 2015 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Date of change 9 October 2015 No. of securities held prior to change Class 1. 1,819,774 Ordinary Shares (direct) 2. 477,500 Ordinary Shares (indirect) Fairley Family Super Fund Pty Ltd 3. 55,000 Ordinary Shares (indirect) Dr Ian Fraser 4. 2,310,000 Performance Right (SPLAK) Performance Rights and Ordinary Shares Number acquired 278,250 Ordinary Shares Number disposed 300,000 Performance Rights Value/Consideration Nil Note: If consideration is non-cash, provide details and estimated valuation + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Appendix 3Y Change of Director’s Interest Notice No. of securities held after change Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back 1. 2,098,024 Ordinary Shares (direct) 2. 477,500 Ordinary Shares (indirect) Fairley Family Super Fund Pty Ltd 3. 55,000 Ordinary Shares (indirect) Dr Ian Fraser 4. 2,010,000 Performance Right (SPLAK) 1. Vesting of 278,250 Performance Rights with a vesting date of 30 September 2015 upon satisfaction of performance conditions. 2. Lapse of 21,750 Performance Rights with a vesting date of 30 September 2015 as performance conditions were not met. Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) Date of change N/A N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Note: If consideration is non-cash, provide details and an estimated valuation Part 3 – +Closed period Were the interests in the securities or contracts detailed No above traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade N/A to proceed during this period? If prior written clearance was provided, on what date was this N/A provided? + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011